Multiple Sclerosis Research and CBD (Cannabidiol)

Care and Feeding of Your Endocannabinoid System
Human Already Have an Endocannabinoid System One of the greatest advantages for publicly traded companies is their ability to raise capital in public markets. Capital can be used to fund research and development (R&D), fund capital expenditure, or even be used to pay off existing debt. This advantage is even more crucial for small biotechnology companies. Because of long lead... Continue
Endocannabinoid System – ECS the Secret To Balanced Health?
The Endocannabinoid System: The Secret To Balanced Health? “I would like to probably push ahead and tell people: Here we have a group of compounds… an endogenous system of major importance… it is not being used as much as it should be in the clinic… it is of great promise in the clinic… let’s try to push it forward.” –... Continue
Synthetic CBD vs Whole Plant CBD
Big Pharma’s Big Problem: How Whole Plant CBD Is Turning the Tables On Synthetic CBD Big Pharma’s playbook for drug development and patents is the same as it’s always been. Large pharmaceutical companies will either invest billions into research and development and ride the seven-year journey from a drug’s discovery, to patent, to its first commercial sale, or they skip... Continue

Multiple Sclerosis (MS) Research Continued